Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling-Reference-Cited by-同舟云学术

Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling

Published:2020-07 Issue: Volume:257 Page:112796
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Li Jiansheng,Ma Jindi,Tian Yange,Zhao Peng,Liu Xuefang,Dong Haoran,Zheng Wanchun,Feng Suxiang,Zhang Lanxi,Wu Mingming,Zhu Lihua,Liu Shuai,Zhao Di

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference38 articles.

1. Exendin-4 restores airway mucus homeostasis through the GLP1R-PKA-PPARgamma-FOXA2-phosphatase signaling;Choi;Mucosal Immunol.,2020

2. Louqin zhisou decoction inhibits mucus hypersecretion for acute exacerbation of chronic obstructive pulmonary disease rats by suppressing EGFR-PI3K-AKT signaling pathway and restoring Th17/Treg balance;Feng;Evid. base Compl. Alternative Med.,2019

3. Repair and remodeling of airway epithelium after injury in chronic obstructive pulmonary disease;Ganesan;Curr Respir Care Rep,2013

4. Traditional Chinese medicine tonifying kidney therapy (Bu shen) for stable chronic obstructive pulmonary disease: protocol for a systematic review and meta-analysis;Gao;Medicine (Baltim.),2018

5. Activation of the EGF receptor by histamine receptor subtypes stimulates mucin secretion in conjunctival goblet cells;He;Invest. Ophthalmol. Vis. Sci.,2018

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective-component compatibility of Bufei Yishen formula alleviates chronic obstructive pulmonary disease inflammation by regulating GSK3β-mediated NLRP3 inflammasome activation;Biomedicine & Pharmacotherapy;2023-12

2. Therapeutic potential of Lianhua Qingke in airway mucus hypersecretion of acute exacerbation of chronic obstructive pulmonary disease;Chinese Medicine;2023-11-03

3. Effective-compound combination of Bufei Yishen formula III combined with ER suppress airway mucus hypersecretion in COPD rats: via EGFR/MAPK signaling;Bioscience Reports;2023-11

4. Astragaloside IV against Alzheimer's disease via microglia-mediated neuroinflammation using network pharmacology and experimental validation;European Journal of Pharmacology;2023-10

5. Progression of the PI3K/Akt signaling pathway in chronic obstructive pulmonary disease;Frontiers in Pharmacology;2023-09-20